Author: Mark Newman

Share

Tipping the Scales: Noninvasive Obesity Breakthroughs

June2022CoverEN As the worldwide mortality rate linked to obesity and its comorbidities surpasses four million annually, new approaches to combating this condition are sorely needed. Thankfully, recent research from Endocrine Society journals shows promise in some surprisingly novel and safe noninvasive weight loss methods. The obesity epidemic continues to pose serious health threats to populations worldwide....
Share

Middle Management: Evaluating New Insights to Obesity and Weight Control Options

June2022CoverEN As obesity continues to reach epidemic proportions, endocrine researchers are at the forefront of discovering new methods to help clinicians and patients alike to manage and even conquer obesity and its plethora of comorbidities. Here, we look at three recent studies that take these solutions from the bench to the bedside and even to the...
Share

David Harlan, MD, Named Director, JDRF Center of Excellence, New England 

david-harlan-500x500 Endocrine Society member David M. Harlan, MD, the William and Doris Krupp Professor of Medicine, professor of medicine and co-director of the Diabetes Center of Excellence, has been named the new director of the JDRF Center of Excellence in New England. “For many years, JDRF has supported the collaborative work of Dr. Harlan and his...
Share

New Cushing’s Syndrome Research Presented at ENDO 2022

The pharmacology data focus on the human body’s homeostatic response to potent HSD-1 inhibition by SPI-62. Results highlight that urinary free cortisol is distinct from intracellular cortisol that causes symptoms in patients with Cushing’s syndrome or autonomous cortisol secretion. Sparrow Pharmaceuticals, a clinical-stage biopharmaceutical company developing novel, targeted therapies to address unmet needs in both endocrinology...
Share

Q&A: Mary Korytkowski, MD, and Ranganath Muniyappa, MD, PhD

ENDO_2022_4C Ahead of their ENDO 2022 session on Monday June 13 from 11:00 a.m. to 12:30 p.m., Endocrine News talks with Mary Korytkowski, MD, and Ranganath Muniyappa, MD, PhD, chairs of the guideline development panel that created the latest Endocrine Society Clinical Practice Guideline on treating adult patients with hyperglycemia in a hospital setting. This month,...
Share

Endocrine Society’s Clinical Practice Guideline offers recommendations for hospitalized patients with diabetes

Goal-directed glycemic management in the hospital improves patient outcomes and reduces likelihood of readmission. ATLANTA—Hospitalized patients with diabetes or hyperglycemia who receive goal-directed glycemic management that includes new technologies for glucose monitoring and pre-discharge diabetes self-management education may have better outcomes and less likelihood of readmission, according to a Clinical Practice Guideline issued today by the Endocrine...
Share

Beige Fat Benefits: Q&A with Shingo Kajimura, PhD

Kajimura_Laureate2022 Endocrine News talks to Shingo Kajimura, PhD, the Endocrine Society’s 2022 Richard E. Weitzman Outstanding Early Career Investigator Laureate Award, about his research of brown and beige fat, challenges his lab faced during the pandemic, and why early-career researchers should just make sure the “science works out.”   With his significant contributions to changing how...
Share

Endocrine Society Advises EU Policymakers on Chemicals Strategy 

As part of our global advocacy for science-based policies to reduce exposure to harmful endocrine-disrupting chemicals (EDCs), the Endocrine Society has a seat on an advisory body to the European Commission on the implementation of the Chemicals Strategy for Sustainability (CSS). On May 18, members of the advisory met in Brussels, Belgium, to adopt a...